Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document

An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review

(2015) G. Norman et al.   BMJ Open

Shorter-Duration Therapy Using Vincristine, Dactinomycin, and Lower-Dose Cyclophosphamide With or Without Radiotherapy for Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

(2014) David O. Walterhouse et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment

(2013) U Thiel et al.   BRITISH JOURNAL OF CANCER

PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report

(2013) Stephen X. Skapek et al.   PEDIATRIC BLOOD & CANCER

PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification

(2012) Edoardo Missiaglia et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma

(2012) Sara M. Federico et al.   PEDIATRIC BLOOD & CANCER

Rhabdomyosarcoma in infants younger than 1 year

(2011) Suman Malempati et al.   CANCER

Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma

(2011) Abha A. Gupta et al.   CANCER

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

(2011) R. Beverly Raney et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of the Prognostic Value of Assessing Tumor Diameter Versus Tumor Volume at Diagnosis or in Response to Initial Chemotherapy in Rhabdomyosarcoma

(2010) Andrea Ferrari et al.   JOURNAL OF CLINICAL ONCOLOGY

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005

(2009) Simona Ognjanovic et al.   CANCER

Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients

(2009) Iyad Sultan et al.   JOURNAL OF CLINICAL ONCOLOGY

Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803

(2009) Carola A.S. Arndt et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups

(2008) Odile Oberlin et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group

(2006) Carola A.S. Arndt et al.   PEDIATRIC BLOOD & CANCER